You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 11,273,160


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,273,160 protect, and when does it expire?

Patent 11,273,160 protects GAVRETO and is included in one NDA.

This patent has twenty-seven patent family members in twenty-one countries.

Summary for Patent: 11,273,160
Title:RET inhibitor for use in treating cancer having a RET alteration
Abstract: Disclosed herein are methods for treating a subject afflicted with a cancer having an activating RET alteration by administering an effective amount of a selective RET inhibitor, e.g., Compound 1 or pharmaceutically acceptable salts thereof, including, e.g., administering an amount of 60 mg to 400 mg of the selective RET inhibitor once daily.
Inventor(s): Evans Raab; Erica (Cambridge, MA), Wolf; Beni B. (Cambridge, MA)
Assignee: BLUEPRINT MEDICINES CORPORATION (Cambridge, MA)
Application Number:17/127,041
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a Patent: A Detailed Analysis of United States Patent 11,273,160

Introduction

When analyzing a patent, it is crucial to understand its scope, claims, and the broader patent landscape. This article will delve into the specifics of United States Patent 11,273,160, providing a comprehensive overview of its claims, the process of patent valuation, and the tools available for patent research.

What is a Patent?

A patent is a form of intellectual property that grants the owner exclusive rights to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date. Patents can be highly valuable, as they protect innovative ideas and technologies[1].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of protection granted by the patent. They outline what the inventor considers to be the novel and non-obvious aspects of the invention. The claims must be clear, concise, and supported by the patent's description and drawings[3].

Analyzing the Scope of United States Patent 11,273,160

To analyze the scope of a specific patent like 11,273,160, one must carefully review its claims. Here are the key steps:

Identify the Independent Claims

Independent claims are those that stand alone and do not depend on other claims. These claims define the broadest scope of the invention.

Understand the Dependent Claims

Dependent claims build upon the independent claims, often narrowing the scope by adding additional features or limitations.

Review the Description and Drawings

The patent's description and drawings provide context and support for the claims. They help in understanding how the invention works and its various embodiments.

Valuation of Patents

The value of a patent can be determined using several methods:

Cost Approach

This method considers the cost incurred to develop the patent. Since it is not possible to go back in time to file a patent application, the cost value is what was paid to develop it[1].

Income Approach

This approach looks at the future benefits provided by the patent, such as income or savings. The income value is the present value of these benefits over the patent's lifetime[1].

Market Approach

This method determines the market value by what a willing buyer would pay for a similar asset. This can be based on sales data and asking prices for similar patents[1].

Sales Data and Market Trends

Historical sales data can provide insights into the market value of patents. For example, in 2011, Rockstar Bidco paid $4.5 billion for 6,000 patent documents from Nortel, which translates to $750,000 per patent document. Similarly, Google's acquisition of Motorola Mobility included 24,500 patents and applications, with analysts noting that the deal was primarily about acquiring patents[1].

Tools for Patent Research

Several tools are available for conducting thorough patent research:

USPTO Public Search Facility

The United States Patent and Trademark Office (USPTO) provides a public search facility where users can access patent and trademark information in various formats, including online, microfilm, and print[4].

Global Dossier

This service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related documents[4].

Patent Claims Research Dataset

This dataset, provided by the USPTO, contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. It helps in analyzing patent scope and trends[3].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more integrated view of the global patent landscape[4].

Case Study: Allergan USA, Inc. v. MSN Laboratories Private Ltd.

A recent case involving Allergan USA, Inc. and MSN Laboratories Private Ltd. highlights the importance of patent claims and their validity. The case revolved around the validity of claims related to the drug eluxadoline, with the court ultimately reversing the district court's determination that certain claims were invalid due to obviousness-type double patenting and lack of written description[2].

Key Takeaways

  • Patent Claims: The claims are the most critical part of a patent, defining the scope of protection.
  • Valuation Methods: Cost, income, and market approaches can be used to determine the value of a patent.
  • Research Tools: The USPTO provides several tools, including the Public Search Facility, Global Dossier, and Patent Claims Research Dataset, to aid in patent research.
  • Market Trends: Historical sales data and market trends can provide insights into the value of patents.
  • Legal Considerations: The validity of patent claims can be crucial in legal disputes, as seen in the Allergan USA, Inc. v. MSN Laboratories Private Ltd. case.

FAQs

  1. What is the primary purpose of patent claims?

    • The primary purpose of patent claims is to define the scope of protection granted by the patent, outlining what the inventor considers to be the novel and non-obvious aspects of the invention.
  2. How can the value of a patent be determined?

    • The value of a patent can be determined using the cost approach (development cost), income approach (future benefits), and market approach (sales data and asking prices).
  3. What is the Global Dossier service provided by the USPTO?

    • The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related documents.
  4. Why is the Patent Claims Research Dataset important?

    • The Patent Claims Research Dataset is important because it contains detailed information on claims from U.S. patents and applications, helping in analyzing patent scope and trends.
  5. What is the significance of the Common Citation Document (CCD)?

    • The CCD consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more integrated view of the global patent landscape.

Sources

  1. Perpetual Motion Patents - The Value of a Patent
  2. CAFC - Allergan USA, Inc. v. MSN Laboratories Private Ltd.
  3. USPTO - Patent Claims Research Dataset
  4. USPTO - Search for Patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,273,160

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Rigel Pharms GAVRETO pralsetinib CAPSULE;ORAL 213721-001 Sep 4, 2020 RX Yes Yes 11,273,160 ⤷  Subscribe TREATMENT OF ADULT PATIENTS WITH METASTATIC REARRANGED DURING TRANSFECTION (RET) FUSION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) AS DETECTED BY AN FDA APPROVED TEST ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.